Geron Corp (GERN)

[jeffqdhsr]

From Ash 2020

https://link.springer.com/article/10.1007/s12325-021-01691-0

And again, the imetelstat data, which is a telomerase inhibitor, also showed very promising results with a high rate of transfusion independence in non-deletion 5q patients who were transfusion dependent, and some of these patients really went into complete remission [4]. So in the low-risk group, I think we have exciting new treatments. And all sorts of exciting new ways of treating our patients, treating them earlier and having pre-emptive responses.

Not sure why this drug still has not received approval? jmho